Sector & Market
US Drug Market Rebounds 10% Post-Memorial
Total US drug market grew 10% week-over-week after an 8% decline the previous week.
Tirzepatide (Mounjaro/Zepbound) saw YoY prescription growth of 46% (1‑week), 51% (4‑weeks) and 57% (12‑weeks).
Oral
